Cancer stem cell: Implications in cancer biology and therapy with special reference to lung cancer

Lung Cancer

Volumn 66, Issue 3, 2009, Pages 275-281

  Kitamura, Hitoshi ^a   Okudela, Koji ^a   Yazawa, Takuya ^a   Sato, Hanako ^a,b   Shimoyamada, Hiroaki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer stem cell; Cell marker; Clinicopathological application; Lung cancer; Signaling pathway; Stem cell niche; Therapy

Indexed keywords

ALDEHYDE DEHYDROGENASE; BETA CATENIN; BMI1 PROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; CELL MARKER; HERMES ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR MASH1; TUMOR MARKER; WNT PROTEIN;

ANTIGEN EXPRESSION; CANCER STEM CELL; CANCER THERAPY; CAUSE OF DEATH; CELL ACTIVITY; CELL ASSAY; CELL FUNCTION; CLINICAL FEATURE; GENOMIC INSTABILITY; HUMAN; IN VITRO STUDY; LUNG CANCER; LUNG INJURY; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, DIFFERENTIATION; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG NEOPLASMS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA; STEM CELL NICHE;

EID: 70449522162     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.07.019     Document Type: Review

References (87)

1. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66 (2006) 9339-9344
2. Lobo N.A., Shimono Y., Qian D., and Clarke M.F. The biology of cancer stem cells. Annu Rev Cell Dev Biol 23 (2007) 675-699
3. Rapp U.R., Ceteci F., and Schreck R. Oncogene-induced plasticity and cancer stem cells. Cell Cycle 7 (2008) 45-51
4. Kim C.F., and Dirks P.B. Cancer and stem cell biology: how tightly intertwined?. Cell Stem Cell 3 (2008) 147-150
5. Yang Y.M., and Chang J.W. Current status and issues in cancer stem cell study. Cancer Invest 26 (2008) 741-755
6. Li X., Lewis M.T., Huang J., Gutierrez C., Osborne C.K., Wu M.F., et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100 (2008) 672-679
7. Li L., Borodyansky L., and Yang Y. Genomic instability en route to and from cancer stem cells. Cell Cycle 8 (2009) 1000-1002
8. Hill R.P. Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66 (2006) 1883-1890
9. Kelly P.N., Dakic A., Adams J.M., Nutt S.L., and Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 317 (2007) 337
10. Lewis M.T. Faith, heresy and the cancer stem cell hypothesis. Future Oncol 4 (2008) 585-589
11. Yoo M.H., and Hatfield D.L. The cancer stem cell theory: is it correct?. Mol Cells 26 (2008) 514-516
12. Vezzoni L., and Parmiani G. Limitations of the cancer stem cell theory. Cytotechnology 58 (2008) 3-9
13. Visvader J.E., and Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8 (2008) 755-768
14. Rowan K. Are cancer stem cells real? After four decades, debate still simmers. J Natl Cancer Inst 101 (2009) 546-547
15. Ahn S.M., Goode R.J., and Simpson R.J. Stem cell markers: insights from membrane proteomics?. Proteomics 8 (2008) 4946-4957
16. Klonisch T., Wiechec E., Hombach-Klonisch S., Ande S.R., Wesselborg S., Schulze-Osthoff K., et al. Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol Med 14 (2008) 450-460
17. Ryan D.H., Chapple C.W., Kossover S.A., Sandberg A.A., and Cohen H.J. Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLA-positive B cell precursors. Blood 70 (1987) 814-821
18. Lanza F., Healy L., and Sutherland D.R. Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents 15 (2001) 1-13
19. Stern R. Association between cancer and "acid mucopolysaccharides": an old concept comes of age, finally. Semin Cancer Biol 18 (2008) 238-243
20. Marhaba R., Klingbeil P., Nuebel T., Nazarenko I., Buechler M.W., and Zoeller M. CD44 and EpCAM: cancer-initiating cell markers. Curr Mol Med 8 (2008) 784-804
21. Orian-Rousseau V., and Ponta H. Adhesion proteins meet receptors: a common theme?. Adv Cancer Res 101 (2008) 63-92
22. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15 (2008) 504-514
23. Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G., et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90 (1997) 5002-5012
24. Wuchter C., Ratei R., Spahn G., Schoch C., Harbott J., Schnittger S., et al. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping. Haematologica 86 (2001) 154-161
25. Shmelkov S.V., St Clair R., Lyden D., and Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol 37 (2005) 715-719
26. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 97 (2000) 14720-14725
27. Pötgens A.J., Bolte M., Huppertz B., Kaufmann P., and Frank H.G. Human trophoblast contains an intracellular protein reactive with an antibody against CD133-a novel marker for trophoblast. Placenta 22 (2001) 639-645
28. Salven P., Mustjoki S., Alitalo R., Alitalo K., and Rafii S. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101 (2003) 168-172
29. Richardson G.D., Robson C.N., Lang S.H., Neal D.E., Maitland N.J., and Collins A.T. CD133, a novel marker for human prostatic epithelial stem cells. Cell Sci 117 Pt 16 (2004) 3539-3545
30. Piechaczek C. CD133. J Biol Regul Homeost Agents 15 (2001) 101-102
31. Yu Y., Flint A., Dvorin E.L., and Bischoff J. AC133-2, a novel isoform of human AC133 stem cell antigen. J Biol Chem 277 (2002) 20711-20716
32. Marzesco A.M., Janich P., Wilsch-Bräuninger M., Dubreuil V., Langenfeld K., Corbeil D., et al. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci 118 Pt 13 (2005) 2849-2858
33. Taïeb N., Maresca M., Guo X.J., Garmy N., Fantini J., and Yahi N. The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif. Cancer Lett 278 (2009) 164-173
34. Wang J., Sakariassen P.Ø., Tsinkalovsky O., Immervoll H., Bøe S.O., Svendsen A., et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122 (2008) 761-768
35. Ogden A.T., Waziri A.E., Lochhead R.A., Fusco D., Lopez K., Ellis J.A., et al. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery 62 (2008) 505-514
36. Shmelkov S.V., Butler J.M., Hooper A.T., Hormigo A., Kushner J., Milde T., et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118 (2008) 2111-2120
37. Mizrak D., Brittan M., and Alison M.R. CD133: molecule of the moment. J Pathol 214 (2008) 3-9
38. Bidlingmaier S., Zhu X., and Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 86 (2008) 1025-1032
39. Goodell M.A., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183 (1996) 1797-1806
40. Wu C., and Alman B.A. Side population cells in human cancers. Cancer Lett 268 (2008) 1-9
41. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101 (2004) 14228-14233
42. Hirschmann-Jax C., Foster A.E., Wulf G.G., Goodell M.A., and Brenner M.K. A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapy. Cell Cycle 4 (2005) 203-205
43. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7 (2001) 1028-1034
44. Telford W.G., Bradford J., Godfrey W., Robey R.W., and Bates S.E. Side population analysis using a violet-excited cell-permeable DNA binding dye. Stem Cells 25 (2007) 1029-1036
45. Sophos N.A., and Vasiliou V. Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact 143-144 (2003) 5-22
46. Huang E.H., Hynes M.J., Zhang T., Ginestier C., Dontu G., Appelman H., et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69 (2009) 3382-3389
47. Jones R.J., Barber J.P., Vala M.S., Collector M.I., Kaufmann S.H., Ludeman S.M., et al. Assessment of aldehyde dehydrogenase in viable cells. Blood 85 (1995) 2742-2746
48. Armstrong L., Stojkovic M., Dimmick I., Ahmad S., Stojkovic P., Hole N., et al. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 22 (2004) 1142-1151
49. Corti S., Locatelli F., Papadimitriou D., Donadoni C., Salani S., Del Bo R., et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 24 (2006) 975-985
50. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1 (2007) 555-567
51. Dylla S.J., Beviglia L., Park I.K., Chartier C., Raval J., Ngan L., et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS ONE 3 (2008) e2428
52. Storms R.W., Trujillo A.P., Springer J.B., Shah L., Colvin O.M., Ludeman S.M., et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA 96 (1999) 9118-9123
53. Jiang F., Qiu Q., Khanna A., Todd N.W., Deepak J., Xing L., et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 7 (2009) 330-338
54. Collins A.T., Berry P.A., Hyde C., Stower M.J., and Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65 (2005) 10946-10951
55. Annabi B., Lachambre M.P., Plouffe K., Sartelet H., and Béliveau R. Modulation of invasive properties of CD133(+) glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Mol Carcinogen (2009) 10.1002/mc.20541 (the date of access: July 23, 2009)
56. Li L., and Neaves W.B. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66 (2006) 4553-4557
57. Sneddon J.B., and Werb Z. Location, location, location: the cancer stem cell niche. Cell Stem Cell 1 (2007) 607-611
58. Blanpain C., Horsley V., and Fuchs E. Epithelial stem cells: turning over new leaves. Cell 128 (2007) 445-458
59. van der Flier L.G., and Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71 (2009) 5.1-5.20
60. Alison M.R., and Islam S. Attributes of adult stem cells. J Pathol 217 (2009) 144-160
61. Polakis P. Wnt signaling and cancer. Genes Dev 14 (2000) 1837-1851
62. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 434 (2005) 843-850
63. Otto W.R. Lung epithelial stem cells. J Pathol 197 (2002) 527-535
64. Giangreco A., Groot K.R., and Janes S.M. Lung cancer and lung stem cells: strange bedfellows?. Am J Respir Crit Care Med 175 (2007) 547-553
65. Giangreco A., Arwert E.N., Rosewell I.R., Snyder J., Watt F.M., and Stripp B.R. Stem cells are dispensable for lung homeostasis but restore airways after injury. Proc Natl Acad Sci USA 106 (2009) 9286-9291
66. Besson A., Hwang H.C., Cicero S., Donovan S.L., Gurian-West M., Johnson D., et al. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev 21 (2007) 1731-1746
67. Working group that convened for an editorial and consensus conference in Lyon, France, March 12-16, 2003. In: Travis W.D., Brambilla E., Muller-Hermelink H.K., and Harris C.C. (Eds). Tumours of the lung. World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart (2004), IARC Press, Lyon 9-124 [chapter 1]
68. Kitamura H., Yazawa T., Okudela K., Shimoyamada H., and Sato H. Molecular and genetic pathogenesis of lung cancer: differences between small-cell and non-small-cell carcinomas. Open Pathol J 2 (2008) 106-114 10.2174/1874375700802010106 the date of access: July 23, 2009
69. Dovey J.S., Zacharek S.J., Kim C.F., and Lees J.A. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc Natl Acad Sci USA 105 (2008) 11857-11862
70. Watkins D.N., Berman D.M., Burkholder S.G., Wang B., Beachy P.A., and Baylin S.B. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422 (2003) 313-317
71. Yagui-Beltrán A., He B., and Jablons D.M. The role of cancer stem cells in neoplasia of the lung: past, present and future. Clin Transl Oncol 10 (2008) 719-725
72. Peacock C.D., and Watkins D.N. Cancer stem cells and the ontogeny of lung cancer. J Clin Oncol 26 (2008) 2883-2889
73. Lemjabbar-Alaoui H., Dasari V., Sidhu S.S., Mengistab A., Finkbeiner W., Gallup M., et al. Wnt and Hedgehog are critical mediators of cigarette smoke-induced lung cancer. PLoS ONE 1 (2006) e93
74. Ho M.M., Ng A.V., Lam S., and Hung J.Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67 (2007) 4827-4833
75. Sung J.M., Cho H.J., Yi H., Lee C.H., Kim H.S., Kim D.K., et al. Characterization of a stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun 371 (2008) 163-167
76. Meng X., Wang X., and Wang Y. More than 45% of A549 and H446 cells are cancer initiating cells: evidence from cloning and tumorigenic analyses. Oncol Rep 21 (2009) 995-1000
77. Ucar D., Cogle C.R., Zucali J.R., Ostmark B., Scott E.W., Zori R., et al. Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact 178 (2009) 48-55
78. Patel M., Lu L., Zander D.S., Sreerama L., Coco D., and Moreb J.S. ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer 59 (2008) 340-349
79. Levina V., Marrangoni A.M., DeMarco R., Gorelik E., and Lokshin A.E. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS ONE 3 (2008) e3077
80. Jiang T., Collins B.J., Jin N., Watkins D.N., Brock M.V., Matsui W., et al. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Cancer Res 69 (2009) 845-854
81. Kitamura H., Yazawa T., Sato H., Okudela K., and Shimoyamada H. Small cell lung cancer: significance of RB alterations and TTF-1 expression in its carcinogenesis, phenotype, and biology. Endcr Pathol 20 (2009) 101-107
82. Chen Y.C., Hsu H.S., Chen Y.W., Tsai T.H., How C.K., Wang C.Y., et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 3 (2008) e2637
83. Gutova M., Najbauer J., Gevorgyan A., Metz M.Z., Weng Y., Shih C.C., et al. Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS ONE 2 (2007) e243
84. Koch L.K., Zhou H., Ellinger J., Biermann K., Höller T., von Rücker A., et al. Stem cell marker expression in small cell lung carcinoma and developing lung tissue. Hum Pathol 39 (2008) 1597-1605
85. Hilbe W., Dirnhofer S., Oberwasserlechner F., Schmid T., Gunsilius E., Hilbe G., et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57 (2004) 965-969
86. Choi D., Lee H.W., Hur K.Y., Kim J.J., Park G.S., Jang S.H., et al. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol 15 (2009) 2258-2264
87. Liao X., Siu M.K., Au C.W., Chan Q.K., Chan H.Y., Wong E.S., et al. Aberrant activation of hedgehog signaling pathway contributes to endometrial carcinogenesis through beta-catenin. Mod Pathol 22 (2009) 839-847